JPMorgan Starts Arrowhead Pharma (ARWR) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 62.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.75 | 52 Week High | $8.22 | |||
| Open | $62.75 | 52 Week Low | $3.07 | |||
| Day High | $62.75 | P/E | N/A | |||
| Day Low | $62.75 | EPS | $-1.30 | |||
| Volume | 4 | |||||
